Active Fine Chemicals Limited Stock

Equities

ACTIVEFINE

BD0483ACFCH9

Pharmaceuticals

End-of-day quote Dhaka S.E. 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
14.4 BDT -1.37% Intraday chart for Active Fine Chemicals Limited -7.10% -25.39%
Sales 2021 1.82B 16.61M Sales 2022 1.67B 15.25M Capitalization 5.16B 47.05M
Net income 2021 38M 347K Net income 2022 25M 228K EV / Sales 2021 3.91 x
Net Debt 2021 2.74B 24.98M Net Debt 2022 2.61B 23.85M EV / Sales 2022 4.65 x
P/E ratio 2021
115 x
P/E ratio 2022
199 x
Employees 92
Yield 2021
0.27%
Yield 2022
0.12%
Free-Float 87.96%
More Fundamentals * Assessed data
Dynamic Chart
Active Fine Chemicals Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Active Fine Chemicals Limited Has Recommends Cash Dividend for the Year Ended on June 30, 2022 CI
Active Fine Chemicals Limited Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
Active Fine Chemicals Limited Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Active Fine Chemicals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021 CI
Active Fine Chemicals Limited Recommends Cash Dividend for the Year Ended on June 30, 2019 CI
Active Fine Chemicals Ltd. Reports Earnings Results for the Third Quarter Ended March 31, 2019 CI
Active Fine Chemicals Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2018 CI
Active Fine Chemicals Ltd. Announces Earnings Results for the Year Ended June 30, 2018 CI
Active Fine Chemicals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2018 CI
Active Fine Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018 CI
Active Fine Chemicals Limited Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 2017 CI
Active Fine Chemicals Limited Reports un-audited Earnings Results for the first quarter Ended September 30, 2017 CI
Active Fine Chemicals Limited Reports Earnings Results for the Year Ended June 30, 2017 CI
Active Fine Chemicals Limited Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 2017 CI
More news
1 day-1.37%
1 week-7.10%
Current month-4.00%
1 month-3.36%
3 months-25.39%
6 months-25.39%
Current year-25.39%
More quotes
1 week
14.20
Extreme 14.2
15.70
1 month
14.00
Extreme 14
16.10
Current year
13.00
Extreme 13
21.50
1 year
13.00
Extreme 13
21.50
3 years
13.00
Extreme 13
34.10
5 years
10.50
Extreme 10.5
34.10
10 years
10.50
Extreme 10.5
41.67
More quotes
Managers TitleAgeSince
Chief Executive Officer 45 04-11-30
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 45 04-11-30
Chairman 44 04-11-30
Founder 48 04-11-30
More insiders
Date Price Change Volume
24-04-18 14.4 -1.37% 315,305
24-04-17 14.6 -0.68% 507,732
24-04-16 14.7 +0.68% 365,950
24-04-15 14.6 -5.81% 258,624

End-of-day quote Dhaka S.E., April 17, 2024

More quotes
Active Fine Chemicals Limited is a Bangladesh-based manufacturer of active pharmaceutical ingredients (APIs) and lab reagents. The Company is primarily engaged in the producing bulk drugs/ API and different laboratory reagents. Its APIs include Azithromycin Dihydrate; Erythromycin Ethyl Succinate; Erythromycin Stearate; Esomeprazole Magnesium Trihydrate; Esomeprazole Magnesium Pellets; Pantoprazole Sodium Sesquihydrate; Fluconazole; Atorvastatin Calcium; Cetirizine Hydrochloride; Fexofenadine Hydrochloride; Desloratadine; Venlafaxine HCL; Cefixime Trihydrate, Cefuroxime Axetil, Metformin Hydrochloride; Sitagliptin Phosphate Monohydrate; Vidagliptin; Gliclazide; Glimepiride; Pregabalin; Losartan Potassium; Amlodipine Besylate; Etoricoxib; Ketorolac Tromethamine and Ticagrelor. The Company’s laboratory Reagent category includes products, such as HPLC Grade solvents, Solvents and Powder reagents. Its factory is located in West Muktarpur, Munshiganj, Bangladesh.
More about the company
  1. Stock Market
  2. Equities
  3. ACTIVEFINE Stock